Financial Daily from THE HINDU group of publications
Friday, Jan 09, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Industry & Economy - Pharmaceuticals


Duty cut a great development: Piramal

Our Bureau

Mumbai , Jan. 8

PHARMACEUTICAL companies have welcomed the decision of the Government to pare down customs duty on specified life-saving drugs, formulations and medical equipments to 5 per cent.

Dr Swati Piramal, Director (Strategic Alliance) of Nicholas Piramal India Ltd, described the customs duty cut as a "great development, especially for the patients who are very ill, as this will ease their burden."

A section of the industry, however, did not appear to be very excited about the custom duty reduction in the light of the elaborate and time-consuming procedure involved in getting the status of a `specified life saving drug' from the Government to avail of the duty cut.

Industry players also felt that the customs duty cut should have been extended to research equipment, especially as the clinical research sector in India is growing at a fast clip. Said an industry analyst: "India has a great potential to serve the global pharma market in the area of clinical trials an in order to realise this potential, the industry needs to focus on improving infrastructure, including research equipment. Hence a cut in duty in this segment would have accelerated growth."

Agreed Dr Piramal: "we hope that in the future we will see some reductions in customs duty on research equipment for pharmaceuticals, biotechnology and life sciences industry."

A majority of the players in the industry did not seem to be worried about a possible adverse impact of the lowering of prices of imported life saving drug as an upshot of the custom duty cut on the Indian pharmaceutical industry.

Said Dr Kamal K Sharma, Managing Director of Lupin Ltd, one of India's leading manufacturers of life saving drugs: "I am confident that the lowering of customs duty will not have much of an adverse impact on the Indian industry, because prices in India are already among the lowest in the world. "

More Stories on : Pharmaceuticals | Budget

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
North-east monsoon signs off


Jaswant woos consumers — Slashes duties on a wide range of goods
Rationalisation of customs and excise duties may cost Rs 9,000 cr
`Measures to spur growth'
Details of duty changes
With customs duty cut, scrapping of SAD — `Mobile handset prices likely to drop 8-10 pc'
PC prices to drop as Govt cuts excise duty
Tax sops to boost aviation industry
`Mini Budget' keeps India Inc busy
Hardware sector hails duty cut
`Further fillip to buoyant markets'
Life saving drugs to cost less
Good news for e-signature firms
Domestic airfares set to move southwards by 13-15 pc
Market sizzles, Sensex soars
A loud signal for early polls
Keep boarding card to get tax refund
`Sops will fuel hardware demand'
Chambers gung-ho
Hyderabad Corporation okays budget estimates
Cement industry sees marginal benefit on coal duty cut
`India's perception in West is changing'
Chhattisgarh, M.P., Delhi CMs woo India Inc
CETMA welcomes customs duty cut, removal of SAD
Consumer durables: Less pricey, more competitive
Capital goods: On thin edge
Krishna Institute of Medical Sciences to be opened on Sunday
Study on causes of death
TB control programme
Biocon's Pulse Polio drive
Hotels and tourism — More room for optimism
Petrochemicals: Party in the pipeline
Cabinet clears oil storage at three coastal locations
Duty cut a great development: Piramal
Power: A positive push for power
`No benefits for power sector in short term'
Steel: Firm prices save the day
GMCI calls for taxes rationalisation
Yarn exporters' bid to cash in on firm enquiries
Tyres: A better tread
Water supply projects in AP
`Cut in duty will not bring down coal prices'
`Duty cut on non-coking coal will not raise imports'
Flat rate additional duty for liquor imports sought
FMCGs: Cuts both ways
CAS successful in Delhi, say operators
Non-ferrous metals: Sheen to continue
Paper: No blots
Y.K. Modi is new FICCI President
Biotech meet from Jan 15 in Mangalore
Sand miners' protest in Kerala
Early polls won't hinder disinvestment process
Allotment ratio of GAIL, ONGC shares after bids: Shourie
Commerce Ministry told to review FDI policy in retail
Meet on tackling high non-value addition expenses
Malaysia keen on labour pact
Hyderabad engagements
Kerala remains hostile to entrepreneurship: Study



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line